製品名:Methyl 3-Amino-2-Chloro-6-Fluorobenzoate

IUPAC Name:methyl 3-amino-2-chloro-6-fluorobenzoate

CAS番号:1268830-74-5
分子式:C8H7ClFNO2
純度:95%+
カタログ番号:CM448010
分子量:203.6

包装単位 有効在庫 価格(USD) 数量
CM448010-100mg 3-4 Weeks ƓNJư
CM448010-250mg 3-4 Weeks ǤưŢ
CM448010-1g 4-5 Weeks NJȎǤ
CM448010-5g 5-6 Weeks ƓȎůǵ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:1268830-74-5
分子式:C8H7ClFNO2
融点:-
SMILESコード:COC(=O)C1=C(Cl)C(N)=CC=C1F
密度:
カタログ番号:CM448010
分子量:203.6
沸点:
MDL番号:MFCD24646162
保管方法:

Column Infos

Tinlorafenib
The Journal of Medicinal Chemistry releases an article titled "Identification of the Clinical Candidate PF-07284890 (ARRY-461), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer". Mutations in the BRAF gene result in MAPK pathway activation that are most commonly found in human melanomas. The BRAF V600E mutation is among the most frequent types. Present BRAF inhibitors have significantly improved treatment outcomes for patients with BRAF V600-mutant cancers. However, their effectiveness is limited by disease progression in the brain as they don’t adequately penetrate the blood-brain barrier (BBB).
Pfizer’s Tinlorafenib (formerly PF 07284890) is a highly brain-penetrant inhibitor of BRAF V600-mutant tumors, and currently in a phase 1 clinical trial (NCT04543188). 

Related Products